Abstracts (HTML) List of Authors

Abicht, Angela

P 1081. PTEN-Associated Macrocephaly in a 3-Year-Old Girl
P 409. The Noonan’s Syndrome as a Differential Diagnosis of a Congenital Myasthenic Syndrome
P 956. Next-Generation Sequencing in Patient Care—Arrived or Rejected in Rare Diseases?
P 1077. Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation (LBSL): A Case Report

Adam, Kristine

P 329. Patients with Juvenile Huntington’s Disease Benefit from Early Diagnosis
P 326. Developments in Stem Cell Transplantation in Lysosomal Storage Diseases—An Update on the Example of Mucopolysaccharidoses
P 736. Benign Enlargement of Subarachnideal Spaces and Subdural Hematoma in an Infant: Spontaneous Bleeding, Child Abuse, or Bleeding Disorder?

Adam, Rüdiger

P 1106. Involvement of the Cardial Autonomous Nervous System in Mitochondrial Neurogastrointestinal Encephalopathy Syndrome

Ajayi, Temitayo

FV 1183. Long-Term Safety and Efficacy of Intraventricular Enzyme Replacement Therapy in CLN2 Disease: 2-Year Results from an Ongoing Multicenter Extension Study

Aktas, Orhan

P 1168. Management of Highly Active MS in Children: Successful Early Escalation Therapy with Alemtuzumab

Alfano, Lindsay N.

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Alhaddad, Bader

FV 697. Biallelic Mutations in SCYL1 Cause CALFAN-Syndrome (Cholestasis, Acute Liver Failure, and Neurodegeneration), A Congenital Disorder of Intracellular Trafficking with a Variable Neurological Phenotype

Almusafri, Fatima

FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Althaus, Jürgen

FV 837. Early Withdrawal of Antiepileptic Medication in Patients with Juvenile Myoclonic Epilepsy Is Justifiable!
P 856. Andermann’s Syndrome—Symptom Complex of Agenesis of the Corpus Callosum and Motor–Sensory Neuropathy
P 644. Diagnosis of Muscle–Eye–Brain Disease through Characteristic Neuroradiological Findings

Altmüller, Janine

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B
FV 241. Mutations in NFE2L2 Lead to a Novel Treatable Neurological Disorder with Leukoencephalopathy

Al-Zaidy, Samiah

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Amedick, Lucas Bastian

FV 948. Diffusion Tensor Imaging Parameters in Metachromatic Leukodystrophy: Biomarkers for Disease Progress and Therapeutically Therapeutic Evaluation

Ammann, Louisa

FV 300. Living with Severe Rare Chronic Neurological Disease in Childhood: Family Burden and Quality of Life in Families with MLD and PCH2

Antonio-Arce, Victoria San

FV 269. Cannabidiol for Treatment of Childhood Epilepsy—A Cross-Sectional Survey

Arens, Michael

FV 318. Infant Automated Motion Recognition Technology Using RGB-Depth Sensors for Markerless, Rater-Independent Detection of Abnormal Movements in Early Infancy—In a Motion Project

Arnold, W. Dave

IP 853. AVXS-101 Phase-1-Gene Therapy Clinical Trial in SMA Type 1: Event-Free Survival and Achievement of Developmental Milestones

Asenbauer, Elisabeth

FV 588. Probing Homeostatic and Metaplastic Mechanisms of Synaptic Plasticity in Human Primary Motor Cortex Using High-Frequent Quadri-pulse Theta Burst Stimulation

Assmann, Birgit

FV 747. Early-Onset Progressive Dystonia in Childhood with New Mutations in KMT2B
P 256. Use of Ketogenic Diets in patients with Epilepsy and Metabolic Disorders in Germany, Austria, and Switzerland

Auber, Bernd

P 411. GNAO1-Associated Hyperkinetic-Dystonic Movement Disorder and Developmental Delay in a 14-Year-Old Girl